Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $16.72, but opened at $16.00. Sysmex shares last traded at $16.17, with a volume of 14,584 shares trading hands.
Sysmex Stock Performance
The company has a market capitalization of $10.19 billion, a PE ratio of 28.91 and a beta of 1.14. The company has a 50 day moving average of $16.92 and a two-hundred day moving average of $17.98. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.97 and a quick ratio of 2.30.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share for the quarter, missing analysts' consensus estimates of $0.16 by ($0.04). The firm had revenue of $958.89 million during the quarter, compared to the consensus estimate of $991.22 million. Sysmex had a net margin of 10.56% and a return on equity of 11.81%. As a group, equities research analysts predict that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.
Sysmex Company Profile
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
